Search Results 751-760 of 18336 for Hepatitis C

  1. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

    Has active or uncontrolled hepatitis B or C infection; subject is positive for hepatitis B or C virus (HBV and HCV, respectively) based on the evaluation of ...

  2. HPV infection - Doctors and departments - Mayo Clinic

    Cachay, M.D.. Infectious Disease Specialist. Phoenix, AZ. Areas of focus: Anoscopy, Valley fever, Hepatitis C, HPV infection, Sexually transmitted disease, HIV ...

  3. Joseph C. Hung, Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Operation of clinical nuclear pharmacy; Preparation and quality control (QC) of radiopharmaceuticals; Regulatory issues related to nuclear pharmacy and ...

  4. Publications - David C. Patchett, D.O. - Mayo Clinic

    Priorello LJ, Sperry JA, Yee CI, Kapoor S, Patchett DC, Townsend CO. Pilot study of an integrative telehealth group intervention for chronic pain.

  5. Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305) - Mayo Clinic

    ... c\]), or T3 to T4 due to multiple lung nodules that are too extensive or ... hepatitis C infection (participants with hepatitis C that achieve a ...

  6. Evaluation of C-Scan Capsule in Identifying Subjects With Elevated Risk of Colon Polyps - Mayo Clinic

    The main objective of the study is to determine the ability of the C-Scan system to identify subjects who are at elevated risk for colon polyps. This will be ...

  7. Study to Determine the Effectiveness and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    Patients with positive HBcAb are eligible for the study only if hepatitis B virus DNA level is undetectable. Established diagnosis of hepatitis C viral (HCV) ...

  8. Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies - Mayo Clinic

    ... hepatitis C may be eligible for the HCC expansion cohort (Cohort 13), but HCC patients with co-infection of hepatitis B and C are excluded. Patients with ...

  9. Publications - Kevin O. Leslie, M.D. - Mayo Clinic

    Helmers RA, Byrne TJ, Wesselius LJ, Leslie KO. Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient. Mayo ...

  10. A Study to Evaluate the Effectiveness and Safety of Obeticholic Acid to Treat Patients with Primary Sclerosing Cholangitis - Mayo Clinic

    Autoimmune hepatitis; Hepatitis B virus (unless seroconverted and no positive Hepatitis B Virus DNA); Hepatitis C virus and overlap syndrome. Known Gilbert's ...